Anti-Mullerian hormone (AMH) level ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 1 |
13. 多発性硬化症／視神経脊髄炎
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05754593 (ClinicalTrials.gov) | April 2023 | 21/2/2023 | Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group | Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis, Compared to a Control Group | Multiple Sclerosis | Biological: Anti-Mullerian hormone (AMH) level;Other: Antral follicle count (AFC);Other: Clinical assessment | University Hospital, Bordeaux | NULL | Not yet recruiting | 25 Years | 35 Years | Female | 160 | N/A | France |